Neuspera Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 38

Employees

  • Latest Deal Type
  • Series D

  • Latest Deal Amount
  • $24.2M

  • Investors
  • 19

Neuspera General Information

Description

Developer of implantable neurostimulation medical device systems intended for treating chronic conditions such as urinary urge incontinence and peripheral nerve-related disorders. The company's platform utilizes ultra-miniaturized, wirelessly powered implants combined with external wearable transmitters, delivers targeted neuromodulation therapy through devices implanted near nerves, supports communication and control via clinician programming interfaces, incorporates battery-free or externally powered designs to reduce surgical complexity and complications, enables minimally invasive implantation procedures, and provides adaptive energy transfer technology for deep-tissue operation, enabling patients and healthcare providers to access less invasive, flexible, and functionally efficient treatment alternatives.

Contact Information

Formerly Known As
Vivonda Medical
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 51 Daggett Drive
  • San Jose, CA 95134
  • United States
+1 (888)
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • 51 Daggett Drive
  • San Jose, CA 95134
  • United States
+1 (888)

Neuspera Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Neuspera Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series D) 18-Jun-2024 $24.2M Completed Generating Revenue
6. Accelerator/Incubator 29-May-2024 Completed Generating Revenue
5. Later Stage VC (Series CC) 01-Sep-2022 Completed Generating Revenue
4. Later Stage VC (Series C) 09-Jun-2021 Completed Generating Revenue
3. Later Stage VC (Series B) 17-Jan-2018 Completed Generating Revenue
2. Early Stage VC (Series A) 26-Apr-2016 $8.89M $8.89M Completed Startup
1. University Spin-Out 03-Dec-2013 Completed Startup
To view Neuspera’s complete valuation and funding history, request access »

Neuspera Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series DD
Series D
Series CC
Series C-1
Series C
Series B 2,187,574 $0.010000 8% $8.11 $8.11 1x $5.51 4.92%
Series A 1,409,412 $0.010000 8% $6.31 $6.31 1x $4.93 2.75%
To view Neuspera’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Neuspera Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of implantable neurostimulation medical device systems intended for treating chronic conditions such as urinar
Therapeutic Devices
San Jose, CA
38 As of 2026

San Mateo, CA
 

Minneapolis, MN
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Neuspera Competitors (48)

One of Neuspera’s 48 competitors is Cala Health, a Venture Capital-Backed company based in San Mateo, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cala Health Venture Capital-Backed San Mateo, CA
ShiraTronics Venture Capital-Backed Minneapolis, MN
Neuromonics Formerly VC-backed Calabasas, CA
Advanced Bionics Formerly VC-backed Valencia, CA
Curonix Private Equity-Backed Pompano Beach, FL
You’re viewing 5 of 48 competitors. Get the full list »

Neuspera Patents

Neuspera Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250288816-A1 Trialing system for sacral neuromodulation therapy Pending 14-Mar-2024
WO-2025064816-A1 Midfield transmitter polarization techniques Inactive 20-Sep-2023
AU-2021342061-A1 Implantable device fixation mechanisms Active 08-Sep-2020
AU-2021342061-B2 Implantable device fixation mechanisms Active 08-Sep-2020
EP-4210810-A1 Implantable device fixation mechanisms Pending 08-Sep-2020 A61N1/37518
To view Neuspera’s complete patent history, request access »

Neuspera Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neuspera Investors (19)

Investor Name Investor Type Holding Investor Since Participating Rounds
120 Capital Venture Capital Minority
Cerity Partners Ventures Corporate Venture Capital Minority
Foreground Capital Venture Capital Minority
Olympus Innovation Ventures Corporate Venture Capital Minority
Revelation Partners Venture Capital Minority
You’re viewing 5 of 19 investors. Get the full list »

Neuspera FAQs

  • When was Neuspera founded?

    Neuspera was founded in 2013.

  • Where is Neuspera headquartered?

    Neuspera is headquartered in San Jose, CA.

  • What is the size of Neuspera?

    Neuspera has 38 total employees.

  • What industry is Neuspera in?

    Neuspera’s primary industry is Therapeutic Devices.

  • Is Neuspera a private or public company?

    Neuspera is a Private company.

  • What is the current valuation of Neuspera?

    The current valuation of Neuspera is .

  • What is Neuspera’s current revenue?

    The current revenue for Neuspera is .

  • How much funding has Neuspera raised over time?

    Neuspera has raised $128M.

  • Who are Neuspera’s investors?

    120 Capital, Cerity Partners Ventures, Foreground Capital, Olympus Innovation Ventures, and Revelation Partners are 5 of 19 investors who have invested in Neuspera.

  • Who are Neuspera’s competitors?

    Cala Health, ShiraTronics, Neuromonics, Advanced Bionics, and Curonix are some of the 48 competitors of Neuspera.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process